Urology
-
Randomized Controlled Trial Multicenter Study Comparative Study Clinical Trial
Long-term 6-year experience with finasteride in patients with benign prostatic hyperplasia.
To summarize the 6-year clinical trial data with finasteride. Benign prostatic hyperplasia is a chronic and progressive disease and therefore assessment of long-term safety and efficacy is important. ⋯ Treatment with finasteride leads to durable improvement in urinary tract symptoms, flow rate, and prostate volume, with no increase in the prevalence of drug-related adverse events over time.